Serum interleukin-6 level predicts short-term clinical response of anti-tumor necrosis factor therapy in patients with ulcerative colitis

Category Primary study
JournalGastroenterology
Year 2017
This article has no abstract
Epistemonikos ID: 559e09ac26aa2713f32dae58b5b7aac29cbe3ebc
First added on: Feb 08, 2025